Global Cord Blood Corporation (CORBF)

OTCMKTS · Delayed Price · Currency is USD
0.950
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
18.75%
Market Cap 127.22M
Revenue (ttm) 196.10M
Net Income (ttm) 79.03M
Shares Out 133.91M
EPS (ttm) 0.65
PE Ratio 1.46
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 2,498
Open 0.950
Previous Close 0.950
Day's Range 0.950 - 0.950
52-Week Range 0.200 - 1.750
Beta -0.71
RSI 49.39
Earnings Date n/a

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Stru... [Read more]

Sector Healthcare
CEO Ting Zheng
Employees 1,202
Stock Exchange OTCMKTS
Ticker Symbol CORBF
Full Company Profile

Financial Performance

In fiscal year 2022, Global Cord Blood's revenue was 1.24 billion, an increase of 7.21% compared to the previous year's 1.16 billion. Earnings were 501.07 million, a decrease of -1.41%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.